R. Landgraf

A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes

Bernhard Paulweber, Paul Valensi, Jaana Lindström et al. · Hormone and Metabolic Research · 2010 · 478 citations · Full text

Medicine, Chronic Disease Prevention, Preventive Medicine +16

A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group.

Bruce H. R. Wolffenbuttel, R. Landgraf · Diabetes Care · 1999 · 129 citations

Medicine, Pharmacology, Pharmacotherapy +17

Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study

Mark Peyrot, R. R. Rubin, T. Lauritzen et al. · Diabetologia · 2006 · 111 citations · Full text

Medicine, Internal Medicine, Diabetology +13

A comparison of repaglinide and glibenclamide in the treatment of type 2 diabetic patients previously treated with sulphonylureas

R. Landgraf, H. J. G. Bilo, P. G. Müller · European Journal of Clinical Pharmacology · 1999 · 92 citations

Medicine, Endocrinology, Pharmacotherapy +13

35th Annual Meeting of the European Association for the Study of Diabetes

Arne Melander, Jonny Olsson, Gunnar Lindberg et al. · Diabetologia · 1999 · 86 citations

Medicine, Endocrinology, Internal Medicine +11